References and Notes
<A NAME="RD35306ST-1A">1a</A>
Bode JW.
Carreira EM.
J. Org. Chem.
2001,
66:
6410
<A NAME="RD35306ST-1B">1b</A>
Kim D.
Lee J.
Shim PJ.
Lim JI.
Doi T.
Kim S.
J. Org. Chem.
2002,
67:
772
<A NAME="RD35306ST-1C">1c</A>
Quan ML.
Pruitt JR.
Ellis CD.
Liauw AY.
Galemmo RA.
Stouten PFW.
Bioorg. Med. Chem. Lett.
1997,
7:
2813
<A NAME="RD35306ST-1D">1d</A>
Groutas WC.
Chong LS.
Epp JB.
Venkataraman R.
Brubaker MJ.
Stanga MA.
Kim E.-H.
Keller CE.
Bioorg. Med. Chem. Lett.
1992,
2:
1571
<A NAME="RD35306ST-2A">2a</A>
Kozikowski AP.
Acc. Chem. Res.
1984,
17:
410
<A NAME="RD35306ST-2B">2b</A>
Jäger V.
Müller I.
Tetrahedron
1985,
41:
3519
<A NAME="RD35306ST-2C">2c</A>
Curran DP.
Scanga SA.
Fenk CJ.
J. Org. Chem.
1984,
49:
3474
<A NAME="RD35306ST-3A">3a</A>
Wallace RH.
Liu J.
Tetrahedron Lett.
1994,
35:
7493
<A NAME="RD35306ST-3B">3b</A>
Wade PA.
D’Ambrosio SG.
Price DT.
J. Org. Chem.
1995,
60:
6302
<A NAME="RD35306ST-4">4</A>
Mizuno K.
Ichinose N.
Tamai T.
Otsuji Y.
J. Org. Chem.
1992,
57:
4669
<A NAME="RD35306ST-5">5</A>
Chang R.
Kim K.
Tetrahedron Lett.
1999,
40:
6773
<A NAME="RD35306ST-6">6</A>
Nagarajan K.
Rajagopalan P.
Tetrahedron Lett.
1966,
5526
<A NAME="RD35306ST-7">7</A>
Molchanov AP.
Stepakov AV.
Kostikov RR.
Zh. Org. Khim.
2004,
40:
1561 ; Russ. J. Org. Chem.; 2004, 40: 1512
<A NAME="RD35306ST-8">8</A>
General Procedures for the Synthesis of 4,5-Dihydro-isoxazolesProcedure a: N-Nitroso-4,5-dihydropyrazole 1 or 3 in PhCl-DMF (or PhCl-AcOH) was irradiated in a sealed reaction vial by the focused
microwave reactor (Minotavr®) at 160 W for the time indicated in Table
[1]
(max. temp. 110 °C). The solvent was distilled off under reduced pressure, and the
residue was purified by crystallization from methanol.
Procedure b: A mixture N-nitroso-4,5-dihydropyrazole 1 or 3 (500 mg) and 2 g silica gel (Chemapol LS 5/40) was irradiated in a focused microwave
reactor (Minotavr®) at 160-200 W for the time indicated in Table
[1]
. In all reactions the compounds were isolated by adding acetone to the mix-ture and
separating the silica gel by filtration. The solvent was removed from the filtrate
under reduced pressure, and the residue was purified by crystallization from MeOH.
<A NAME="RD35306ST-9">9</A>
The reaction vessel was placed in the MW reactor supplied with a safety valve for
release of overpressure.
<A NAME="RD35306ST-10">10</A>
After the set temperature of 110 °C is reached, the power regulates itself to maintain
the reaction temperature.
<A NAME="RD35306ST-11">11</A>
Heating of the reaction mixture in PhCl under microwave activation proceeds very slowly.
The mixture of PhCl with a more polar solvent (AcOH or DMF) was used to allow for
a rapid heating process. Use of the systems PhCl-AcOH and PhCl-DMF as solvents for
realization of thermolysis of N-nitrosodihydropyrazoles by conventional heating leads to a decrease in the yields
of the reaction products (see Table
[1]
).
<A NAME="RD35306ST-12">12</A>
Ethyl 5-(4-Tolyl)-4,6-dioxo-4,5,6,6a-tetrahydro-3a
H
-pyrrolo[3,4-
d
]isoxazole-3-carboxylate (2b)
Mp 166-167 °C. IR (CHCl3): 1040, 1110, 1210, 1380, 1480, 1720, 3050 cm-1. 1H NMR (CDCl3): δ = 1.41 (t, 3 H, J = 7.3 Hz), 2.40 (s, 3 H), 4.44 (q, 2 H, J = 7.3 Hz), 4.89 (d, 1 H, J = 10.2 Hz), 5.71 (d, 1 H, J = 10.2 Hz), 7.15 (d, 2 H, J = 8.0 Hz), 7.29 (d, 2 H, J = 8.0 Hz). 13C NMR (CDCl3): δ = 14.4, 21.6, 54.2, 63.5, 82.6, 126.3, 128.4, 130.4, 140.0, 148.2, 158.8, 169.0,
170.2. Anal. Calcd for C15H14N2O5: C, 59.60; H, 4.67; N, 9.27. Found: C, 59.53; H, 4.71; N, 9.19.
Ethyl 5-(4-Chlorophenyl)-4,6-dioxo-4,5,6,6a-tetrahydro-3a
H
-pyrrolo[3,4-
d
]isoxazole-3-carboxylate (2c)
Mp 159-161 °C. IR (CHCl3): 1050, 1100, 1200, 1390, 1490, 1720, 3050 cm-1. 1H NMR (acetone-d
6): δ = 1.39 (t, 3 H, J = 7.3 Hz), 4.43 (q, 2 H, J = 7.3 Hz), 5.09 (d, 1 H, J = 10.0 Hz), 6.06 (d, 1 H, J = 10.0 Hz), 7.26 (d, 2 H, J = 8.7 Hz), 7.44 (d, 2 H, J = 8.7 Hz). 13C NMR (DMSO-d
6): δ = 14.7, 55.2, 62.9, 82.6, 115.1, 125.0, 129.1, 149.3, 159.1, 160.1, 170.3, 172.1.
Anal. Calcd for C14H11ClN2O5: C, 52.11; H, 3.44; N, 8.68. Found: C, 52.06; H, 3.49; N, 8.61.
Ethyl 5-(4-Ethylphenyl)-4,6-dioxo-4,5,6,6a-tetrahydro-3a
H
-pyrrolo[3,4-
d
]isoxazole-3-carboxylate (2e)
Mp 152-154 °C. IR (CHCl3): 1040, 1110, 1210, 1380, 1470, 1720, 3050 cm-1. 1H NMR (CDCl3): δ = 1.21 (t, 3 H, J = 7.3 Hz), 1.42 (t, 3 H, J = 7.3 Hz), 2.54 (q, 2 H, J = 7.3 Hz), 4.45 (q, 2 H, J = 7.3 Hz), 4.87 (d, 1 H, J = 10.2 Hz), 5.69 (d, 1 H, J = 10.2 Hz), 7.18 (d, 2 H, J = 8.0 Hz), 7.32 (d, 2 H, J = 8.0 Hz). 13C NMR (DMSO-d
6): δ = 13.6, 14.4, 22.8, 54.5, 63.7, 82.6, 125.9, 127.8, 129.7, 139.5, 147.4, 158.6,
168.8, 169.9. Anal. Calcd for C16H16N2O5: C, 60.75; H, 5.10; N, 8.86. Found: C, 60.69; H, 5.14; N, 8.80.
<A NAME="RD35306ST-13">13</A>
The complete set of crystallographic data for ester 2a was deposited to the Cambridge Crystallographic Data Center under the deposition
number CCDC 624122.
<A NAME="RD35306ST-14">14</A>
Ethyl 7-Phenyl-6,8-dioxo-1-oxa-2,7-diazaspiro[4.4]non-2-ene-3-carboxylate (4a)
Mp 127-129 °C. IR (CHCl3): 920, 1060, 1150, 1270, 1390, 1490, 1710, 3050 cm-1. 1H NMR (CDCl3): δ = 1.40 (t, 3 H, J = 7.3 Hz), 3.11 (d, 1 H, J = 18.9 Hz), 3.35 (d, 1 H, J = 18.9 Hz), 3.43 (d, 1 , J = 18.2 Hz), 3.97 (d, 1 H, J = 18.2 Hz), 4.40 (q, 2 H, J = 7.3 Hz), 7.35 (d, 2 H, J = 7.3 Hz), 7.48 (t, 1 H, J = 7.3 Hz), 7.51 (d, 2 H, J = 7.3 Hz). 13C NMR (CDCl3): δ = 14.5, 42.4, 42.6, 63.1, 86.6, 126.6, 129.6, 129.7, 131.5, 151.2, 159.8, 171.8,
173.2. Anal. Calcd for C15H14N2O5: C, 59.60; H, 4.67; N, 9.27. Found: C, 59.66; H, 4.59; N, 9.19.
Ethyl 7-(4-Chlorophenyl)-6,8-dioxo-1-oxa-2,7-diaza-spiro[4.4]non-2-ene-3-carboxylate
(4b)
Mp 179-181 °C. IR (CHCl3): 920, 1040, 1130, 1170, 1270, 1380, 1480, 1730, 3050 cm-1. 1H NMR (CDCl3): δ = 1.39 (t, 3 H, J = 7.3 Hz), 3.11 (d, 1 H, J = 18.9 Hz), 3.36 (d, 1 H, J = 18.9 Hz), 3.42 (d, 1 H, J = 18.2 Hz), 3.97 (d, 1 H, J = 18.2 Hz), 4.40 (q, 2 H, J = 7.3 Hz), 7.32 (d, 2 H, J = 8.7 Hz), 7.49 (d, 2 H, J = 8.7 Hz). 13C NMR (CDCl3 + acetone-d
6): δ = 14.3, 42.3, 42.4, 62.8, 86.7, 127.8, 129.7, 130.2, 135.0, 151.4, 159.7, 171.8,
173.2. Anal. Calcd for C15H13ClN2O5: C, 53.50; H, 3.89; N, 8.32. Found: C, 53.47; H, 3.93; N, 8.27.
Methyl 7-(4-Bromophenyl)-6,8-dioxo-1-oxa-2,7-diaza-spiro[4.4]non-2-ene-3-carboxylate
(4f)
Mp 164-165 °C. IR (CHCl3): 920, 1050, 1140, 1170, 1290, 1380, 1490, 1720, 3050 cm-1. 1H NMR (CDCl3): δ = 3.09 (d, 1 H, J = 18.9 Hz), 3.34 (d, 1 H, J = 18.9 Hz), 3.39 (d, 1 H, J = 18.2 Hz), 3.92 (d, 1 H, J = 18.2 Hz), 3.94 (s, 3 H), 7.24 (d, 2 H, J = 8.7 Hz), 7.62 (d, 2 H, J = 8.7 Hz). 13C NMR (CDCl3): δ = 42.3, 42.4, 53.6, 86.5, 123.5, 128.0, 130.5, 132.9, 151.0, 160.2, 171.4, 172.9.
Anal. Calcd for C14H11BrN2O5: C, 45.80; H, 3.02; N, 7.63. Found: C, 45.77; H, 2.98; N, 7.55.
<A NAME="RD35306ST-15">15</A>
The complete set of crystallographic data for ester 4d was deposited to the Cambridge Crystallographic Data Center under the deposition
number CCDC 624121.
<A NAME="RD35306ST-16A">16a</A>
Grigorova TN.
Ogloblin KA.
Komendantov MI.
Zh. Org. Khim.
1972,
8:
2197
<A NAME="RD35306ST-16B">16b</A>
Grigorova TN.
Ogloblin KA.
Komendantov MI.
Zh. Org. Khim.
1973,
9:
711 ; Russ. J. Org. Chem.; 1973, 9: 732